Similarly, Malik et al. demonstrated that reduced MLH1 expression in breast tumors correlates with higher grade and aggressive clinical features, supporting the hypothesis that attenuation of MLH1 function may influence not only tumor initiation but also progression [29]. This evidence concerns the gene MLH1 and breast neoplasm.